Literature DB >> 25123637

Outcomes of primary surgical evacuation during the first trimester in different types of implantation in women with cesarean scar pregnancy.

Ling-Yun Cheng1, Chen-Bin Wang1, Li-Ching Chu1, Chih-Wen Tseng1, Fu-Tsai Kung2.   

Abstract

OBJECTIVE: To assess the efficacy and safety of primary surgical evacuation therapy for cesarean scar pregnancy (CSP) of the first trimester, and to evaluate its possible prognostic factors.
DESIGN: Retrospective consecutive cohort study.
SETTING: Tertiary care university hospital. SUBJECT(S): A cohort of patients with CSP and clear ultrasound images who underwent primary surgical evacuation from January 2000 to December 2012. INTERVENTION(S): Patients fulfilling the ultrasound criteria of CSP were further classified into superficial and deep groups according to their implantation locations and extents. The final decision on the method of treatment, including methotrexate chemotherapy, surgical evacuation, and others, was made by the patients after consultation with the physician. Pretreatment patient characteristics were compared in the patients with superficial and deep implantation, as were the results after primary surgical evacuation. MAIN OUTCOME MEASURE(S): Rates of successful treatment by primary surgical evacuation of CSP and the need for salvage intervention in the patients with deep and superficial implantation. RESULT(S): Forty-eight CSP patients who had sufficient data and imaging for analysis were enrolled. Of these 48 cases, 26 in the superficial group and 14 in the deep group were willing to undergo primary surgical evacuation. Blood loss and need for salvage intervention were significantly lower in the patients with superficial implantation. Surgical evacuation was successful in 23 of 26 patients (88.5%) with superficial implantation and in 8 of 14 patients (57.1%) with deep implantation. Patients who failed primary surgical evacuation showed complete recovery, with uterus preservation, after salvage interventions, including laparoscopic surgery, angioembolization, and laparotomy. CONCLUSION(S): Preoperative determination of CSP implantation depth and extent is important in selecting candidates for surgical treatment. Primary single-step surgical evacuation was successful in most patients with superficial implantation, but patients should be informed of the possibility of salvage interventions before undergoing surgical evacuation.
Copyright © 2014 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cesarean scar pregnancy; implantation type; primary evacuation therapy

Mesh:

Year:  2014        PMID: 25123637     DOI: 10.1016/j.fertnstert.2014.07.003

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  4 in total

1.  Successful pregnancy located in a uterine cesarean scar: A case report.

Authors:  Shoko Tamada; Hisashi Masuyama; Jota Maki; Takeshi Eguchi; Takashi Mitsui; Eriko Eto; Kei Hayata; Yuji Hiramatsu
Journal:  Case Rep Womens Health       Date:  2017-03-23

2.  The value of transvaginal ultrasound in clinical surgical treatment of cesarean scar pregnancy.

Authors:  Zhen Zeng; Shu-Ping Ding; Xue Zeng; Sui Cao; Ling-Yu Wei; Yan-Yan Liu; Fu-Yan Yang; Jing-Ji Gong; Han-Ping Chen; Xiao-Yan Xu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-08-08

3.  Validation of a 10-Point Scoring System for Treatment of Cesarean Scar Pregnancy.

Authors:  Ting-Ting Tan; Qiu-Lei Sun; Li Luo; Zhu Chen; Xi Xiong; Jin-Hong Xiang; Ping Yan; Chun-Yan Gao; Zheng-Qiong Chen
Journal:  Ther Clin Risk Manag       Date:  2020-05-15       Impact factor: 2.423

4.  Definition and sonographic reporting system for Cesarean scar pregnancy in early gestation: modified Delphi method.

Authors:  I P M Jordans; C Verberkt; R A De Leeuw; C M Bilardo; T Van Den Bosch; T Bourne; H A M Brölmann; M Dueholm; W J K Hehenkamp; N Jastrow; D Jurkovic; A Kaelin Agten; R Mashiach; O Naji; E Pajkrt; D Timmerman; O Vikhareva; L F Van Der Voet; J A F Huirne
Journal:  Ultrasound Obstet Gynecol       Date:  2022-04       Impact factor: 8.678

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.